Related Experiment Video
Updated: May 22, 2025

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Assessment of Vitamin D Metabolism Disorders in Hemodialysis Patients
Maksymilian Hryciuk1, Zbigniew Heleniak1, Sylwia Małgorzewicz1,2
1Department of Nephrology, Medical University of Gdańsk, Dębinki 7 Street, 80-211 Gdańsk, Poland.
Insights
Patients on hemodialysis have lower vitamin D3 reserves and impaired metabolism. The vitamin D metabolism ratio (VMR) is a sensitive indicator of deficiency, and 24,25(OH)2D3 levels are crucial for assessment.
Area of Science:
- Endocrinology
- Nephrology
- Nutritional Science
Background:
- End-stage chronic diseases, particularly hemodialysis (HD), are linked to mineral bone disease (MBD), characterized by hypocalcemia, hyperphosphatemia, and elevated parathyroid hormone (PTH).
- Vitamin D metabolism disorders are prevalent in HD patients, stemming from reduced conversion of 25(OH)D3 to its active form, 1,25(OH)2D3, and impaired inactivation to 24,25(OH)2D3.
Purpose of the Study:
- To evaluate vitamin D metabolite levels, including 25(OH)D2, 25(OH)D3, 24,25(OH)2D3, and 3-epi-25(OH)D3, in patients undergoing maintenance hemodialysis.
- To assess the vitamin D metabolism ratio (VMR) as a marker for vitamin D deficiency in HD patients.
- To compare these levels with a control group of adults without chronic kidney disease (CKD).
Main Methods:
- A cross-sectional study involving 66 patients on maintenance hemodialysis (HD) and 206 healthy adult controls.
- Exclusion of participants receiving cholecalciferol supplementation to ensure accurate baseline metabolite measurements.
- Measurement of various vitamin D metabolites and calculation of the vitamin D metabolism ratio (VMR).
Main Results:
- Hemodialysis patients exhibited significantly lower 25(OH)D3 levels (15 ng/mL vs. 22 ng/mL) and higher deficiency rates (69% vs. 39%) compared to controls.
- HD patients showed reduced levels of 24,25(OH)2D3 (0.1 ng/mL vs. 2.1 ng/mL) and a lower VMR (0.9% vs. 9%), indicating impaired vitamin D catabolism.
- Alphacalcidol supplementation effectively increased 1,25(OH)2D3 levels without altering other vitamin D metabolites, while 25(OH)D2 levels were higher in HD patients.
Conclusions:
- Hemodialysis patients possess diminished vitamin D3 reserves and exhibit both functional vitamin D deficiency and impaired vitamin D3 catabolism compared to the general population.
- The vitamin D metabolism ratio (VMR), which incorporates 24,25(OH)2D3 measurements, is a highly sensitive indicator for assessing vitamin D3 deficiency.
- Alphacalcidol supplementation is effective in raising active vitamin D levels, and 25(OH)D2 is the sole metabolite found at higher concentrations in HD patients.
Background:
Patients with end-stage chronic diseases, especially those undergoing hemodialysis (HD), often experience mineral bone disease (MBD), leading to hypocalcemia, hyperphosphatemia, and elevated parathyroid hormone (PTH). Vitamin D deficiency and metabolism disorders are also common, resulting from impaired conversion of 25(OH)D3 to its active form, 1,25(OH)2D3, and reduced inactivation to 24,25(OH)2D3. This study aimed to assess the levels of 25(OH)D2, 25(OH)D3, 24,25(OH)2D3, 3-epi-25(OH)D3, and the vitamin D metabolism ratio (VMR) in patients with maintenance HD.
Methods:
A cross-sectional study was conducted on 66 HD patients (22-90 years, average 61.3 ± 16.4), with a control group of 206 adults without chronic kidney disease (CKD), both without cholecalciferol supplementation.
Results:
the HD patients had significantly lower 25(OH)D3 levels (15 ng/mL vs. 22 ng/mL) and higher deficiency rates (69% vs. 39%) compared to the controls. However, both groups showed similarly low levels of optimal vitamin D3. The HD patients had lower 24,25(OH)D3 levels (0.1 vs. 2.1 ng/mL) and a lower VMR (0.9% vs. 9%). 3-epi-25(OH)D3 levels and its ratio to 25(OH)D3 were significantly lower in the HD group. Alphacalcidol supplementation raised 1,25(OH)2D3 levels (30.4 vs. 16.2 pg/mL) without affecting other vitamin D metabolites. The HD patients had higher levels of 25(OH)D2 compared to the controls (0.61 vs. 0.31 ng/mL).
Conclusions:
Vitamin D3 reserves are lower, and both functional deficiency and impaired catabolism of vitamin D3 are present in HD patients compared to the general population. The VMR index is the most sensitive parameter for vitamin D3 deficiency assessment, highlighting the importance of measuring 24,25(OH)D3. Alphacalcidol supplementation increases 1,25(OH)2D3 levels without affecting other vitamin D metabolites. 25(OH)D2 is the only metabolite that was higher in HD patients than the controls.
Related Concept Videos
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Skeleton and Calcium Homeostasis

